The tumor antigen WT1 located in the nucleus is overexpressed in both BP-CML and a variety of solid tumor cells, which was associated with drug resistance and poor prognosis. The gene discussed is WT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.